Einträge von Mozgunov, Pavel auf dem Publikationsserver

Kovačević, Luka, Chen, Weishi, Barnett, Helen, Jaki, Thomas und Mozgunov, Pavel (2025) Bayesian model averaging for partial ordering continual reassessment methods. Biostatistics 26 (1). Volltext nicht vorhanden.

Daniells, Libby , Jaki, Thomas , Dayimu, Alimu , Demiris, Nikos, Bristi, Basu, Symeonides, Stefan und Mozgunov, Pavel (2025) Seamless monotherapy-combination phase I dose-escalation model-based design. Clinical Trials 22 (4), S. 430-441.

Daniells, Libby, Mozgunov, Pavel, Barnett, Helen, Bedding, Alun und Jaki, Thomas (2025) Incorporating historic information to further improve power when conducting Bayesian information borrowing in basket trials. Biostatistics 26 (1).

Daniells, Libby , Mozgunov, Pavel , Barnett, Helen, Bedding, Alun und Jaki, Thomas (2025) How to add baskets to an ongoing basket trial with information borrowing. Statistical Methods in Medical Research 34 (4), S. 717-734.

Greenstreet, Peter, Jaki, Thomas , Bedding, Alun und Mozgunov, Pavel (2024) A Preplanned Multi‐Stage Platform Trial for Discovering Multiple Superior Treatments With Control of FWER and Power. Biometrical Journal 67 (1), e70025.

Jaki, Thomas , Barnett, Helen, Titman, Andrew und Mozgunov, Pavel (2024) A seamless Phase I/II platform design with a time-to-event efficacy endpoint for potential COVID-19 therapies. Statistical Methods in Medical Research 33 (11-12), S. 2115-2130.

Greenstreet, Peter, Jaki, Thomas , Bedding, Alun, Harbron, Chris und Mozgunov, Pavel (2024) A multi‐arm multi‐stage platform design that allows preplanned addition of arms while still controlling the family‐wise error. Statistics in Medicine 43 (19), S. 3613-3632.

Barnett, Helen, George, Matthew, Skanji, Donia, Saint-Hilary, Gaelle, Jaki, Thomas und Mozgunov, Pavel (2024) A comparison of model-free phase I dose escalation designs for dual-agent combination therapies. Statistical Methods in Medical Research 33 (2), S. 203-226.

Serra, Alessandra , Mozgunov, Pavel, Davies, Geraint und Jaki, Thomas (2023) Determining the minimum duration of treatment in tuberculosis: An order restricted non‐inferiority trial design. Pharmaceutical Statistics 22 (5), S. 938-962.

Jaki, Thomas , Burdon, Abigail , Chen, Xijin , Mozgunov, Pavel, Zheng, Haiyan und Baird, Richard (2023) Early phase clinical trials in oncology: Realising the potential of seamless designs. European Journal of Cancer 189, S. 112916.

Serra, Alessandra , Mozgunov, Pavel und Jaki, Thomas (2023) A Bayesian multi‐arm multi‐stage clinical trial design incorporating information about treatment ordering. Statistics in Medicine 42 (16), S. 2841-2854.

Daniells, Libby , Mozgunov, Pavel, Bedding, Alun und Jaki, Thomas (2023) A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability‐nonexchangeability method. Statistics in Medicine 42 (24), S. 4392-4417.

Khoo, Saye H, FitzGerald, Richard, Saunders, Geoffrey, Middleton, Calley, Ahmad, Shazaad, Edwards, Christopher J, Hadjiyiannakis, Dennis, Walker, Lauren, Lyon, Rebecca, Shaw, Victoria, Mozgunov, Pavel, Periselneris, Jimstan, Woods, Christie, Bullock, Katie, Hale, Colin, Reynolds, Helen, Downs, Nichola, Ewings, Sean, Buadi, Amanda, Cameron, David, Edwards, Thomas, Knox, Emma, Donovan-Banfield, I'ah, Greenhalf, William, Chiong, Justin, Lavelle-Langham, Lara, Jacobs, Michael, Northey, Josh, Painter, Wendy, Holman, Wayne, Lalloo, David G, Tetlow, Michelle, Hiscox, Julian A, Jaki, Thomas , Fletcher, Thomas, Griffiths, Gareth, Paton, Nicholas, Hayden, Fred, Darbyshire, Janet, Lucas, Amy, Lorch, Ulrika, Freedman, Andrew, Knight, Richard, Julious, Stevan, Byrne, Rachel, Cubas Atienzar, Ana, Jones, Jayne, Williams, Chris, Song, Anna, Dixon, Jan, Alexandersson, Anja, Hatchard, Parys, Tilt, Emma, Titman, Andrew, Doce Carracedo, Ale, Chandran Gorner, Vatsi, Davies, Andrea, Woodhouse, Louis, Carlucci, Nicola, Okenyi, Emmanuel, Bula, Marcin, Dodd, Kate, Gibney, Jennifer, Dry, Lesley, Rashid Gardner, Zalina, Sammour, Amin, Cole, Christine, Rowland, Tim, Tsakiroglu, Maria, Yip, Vincent, Osanlou, Rostam, Stewart, Anna, Parker, Ben, Turgut, Tolga, Ahmed, Afshan, Starkey, Kay, Subin, Sujamole, Stockdale, Jennifer, Herring, Lisa, Baker, Jonathon, Oliver, Abigail, Pacurar, Mihaela, Owens, Dan, Munro, Alistair, Babbage, Gavin, Faust, Saul, Harvey, Matthew, Pratt, Danny, Nagra, Deepak und Vyas, Aashish (2022) Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial. The Lancet Infectious Diseases 23 (2), S. 183-195.

Serra, Alessandra, Mozgunov, Pavel, Jaki, Thomas und Rigat, Fabio (2022) What is the expected benefit of patient-centric clinical development in oncology? Journal of Biopharmaceutical Statistics 32 (3), S. 414-426.

Serra, Alessandra, Mozgunov, Pavel und Jaki, Thomas (2022) An order restricted multi‐arm multi‐stage clinical trial design. Statistics in Medicine 41 (9), S. 1613-1626.

Zheng, Haiyan , Grayling, Michael J, Mozgunov, Pavel, Jaki, Thomas und Wason, James M S (2022) Bayesian sample size determination in basket trials borrowing information between subsets. Biostatistics 24 (4), S. 1000-1016. Volltext nicht vorhanden.

Mozgunov, Pavel, Jaki, Thomas, Gounaris, Ioannis, Goddemeier, Thomas, Victor, Anja und Grinberg, Marianna (2022) Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial. Statistics in Medicine 41 (30), S. 5789-5809. Volltext nicht vorhanden.

Mozgunov, Pavel, Cro, Suzie, Lingford‐Hughes, Anne, Paterson, Louise M. und Jaki, Thomas (2021) A dose‐finding design for dual‐agent trials with patient‐specific doses for one agent with application to an opiate detoxification trial. Pharmaceutical Statistics 21 (2), S. 476-495.

Mozgunov, Pavel, Paoletti, Xavier und Jaki, Thomas (2021) A benchmark for dose-finding studies with unknown ordering. Biostatistics 23 (3), S. 721-737.